Aimmune Therapeutics Inc (AIMT)

Currency in USD
34.49
0.00(0.00%)
Closed·
Showing Aimmune Therapeutics Inc historical data. For real-time data please try another search
Day's Range
34.4834.56
52 wk Range
34.4834.56
Key Statistics
Prev. Close
34.49
Open
34.56
Day's Range
34.48-34.56
52 wk Range
34.48-34.56
Volume
-
Average Volume (3m)
674.52K
1-Year Change
0%
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock

Aimmune Therapeutics Inc News & Analysis

Show more

Aimmune Therapeutics Inc Company Profile

Aimmune Therapeutics, Inc., a biopharmaceutical company, develops and commercializes product candidates for the treatment of peanut and other food allergies. Its lead characterized oral desensitization immunotherapy (CODIT) product candidate is Palforzia, used for the treatment of patients with peanut allergy. The company also engages in the research and development of AR201, a CODIT product candidate that is in a Phase II clinical trial for the treatment of egg allergy in pediatric and young adult patients, and other CODIT product candidates targeting food allergies, such as cow’s milk allergy. Aimmune Therapeutics, Inc. has a strategic collaboration with an affiliate of Nestle Health Science US Holdings, Inc. for the advancement of food allergy therapeutics and a clinical collaboration agreement with Regeneron Ireland Unlimited Company and Sanofi Biotechnology SAS to study PALFORZIA with adjunctive dupilumab in peanut-allergic patients. The company was formerly known as Allergen Research Corporation and changed its name to Aimmune Therapeutics, Inc. in May 2015. Aimmune Therapeutics, Inc. was incorporated in 2011 and is headquartered in Brisbane, California. Aimmune Therapeutics, Inc. operates as a subsidiary of Société des Produits Nestlé S.A.

Earnings

Latest Release
Nov 04, 2021
EPS / Forecast
-- / -0.72
Revenue / Forecast
-- / 25.97M
EPS Revisions
Last 90 days

AIMT Income Statement

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.